MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-06-2026
Mettler-Toledo International Total Non Current Liabilities 2011-2026 | MTD
Annual Total Non Current Liabilities Mettler-Toledo International
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 1.61 B | 1.29 B | 1.31 B | 1.14 B | 843 M | 611 M | 654 M | 728 M | 812 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.61 B | 611 M | 1 B |
Total Non Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
23.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
3.29 B | $ 115.38 | 0.26 % | $ 35.1 B |  USA |
 |
BioNano Genomics
BNGO
|
16.4 M | $ 1.13 | - | $ 6.15 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
61.1 M | $ 15.65 | -2.86 % | $ 168 M |  China |
 |
Aspira Women's Health
AWH
|
3.49 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
11.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
24.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
16 K | - | - | $ 9.42 M |  Israel |
 |
DermTech
DMTK
|
865 K | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
17.9 M | $ 16.19 | 0.87 % | $ 863 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
7.74 M | - | - | $ 562 M |  Britain |
|
Akumin
AKU
|
527 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
4.6 M | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
574 K | $ 1.38 | 0.36 % | $ 1.84 M | USA |
 |
Exact Sciences Corporation
EXAS
|
981 M | - | - | $ 19.8 B | USA |
 |
Interpace Biosciences
IDXG
|
10 M | $ 2.3 | - | $ 10.2 M | USA |
 |
Accelerate Diagnostics
AXDX
|
134 M | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
2.76 M | $ 23.22 | 0.39 % | $ 645 M | USA |
 |
Global Cord Blood Corporation
CO
|
2.53 B | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
131 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
559 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
48.5 M | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
2.35 B | $ 174.38 | -0.74 % | $ 8.64 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.43 B | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
73.8 M | $ 498.0 | 0.91 % | $ 14.4 B | USA |
 |
Danaher Corporation
DHR
|
26.9 B | $ 189.16 | -0.22 % | $ 135 B | USA |
 |
Heska Corporation
HSKA
|
57.9 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
4.1 M | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
2.04 B | $ 121.65 | 0.6 % | $ 19.3 B | USA |
 |
Myriad Genetics
MYGN
|
107 M | $ 4.37 | 0.34 % | $ 405 M | USA |
 |
NeoGenomics
NEO
|
435 M | $ 7.79 | 1.3 % | $ 998 M | USA |
 |
Fulgent Genetics
FLGT
|
2.26 M | $ 14.67 | 1.66 % | $ 444 M | USA |
 |
Guardant Health
GH
|
91.4 M | $ 79.04 | 0.55 % | $ 9.91 B | USA |
 |
QIAGEN N.V.
QGEN
|
1.99 B | - | - | $ 10.6 B |  Niderland |
 |
Anixa Biosciences
ANIX
|
4.17 M | $ 2.73 | 1.49 % | $ 88.6 K | USA |
 |
Biomerica
BMRA
|
1.57 M | $ 2.08 | -2.8 % | $ 4.78 M | USA |
 |
Invitae Corporation
NVTA
|
320 M | - | - | $ 21.2 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
8.08 B | $ 28.22 | -0.3 % | $ 20 B | Niderland |
 |
ICON Public Limited Company
ICLR
|
461 M | $ 107.7 | 0.83 % | $ 8.88 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
7.82 B | $ 260.87 | -0.02 % | $ 21.7 B | USA |
 |
Natera
NTRA
|
124 M | $ 196.81 | 1.96 % | $ 19.4 B | USA |
 |
Celcuity
CELC
|
69.2 K | $ 120.91 | 3.22 % | $ 5.65 B | USA |
 |
Lantheus Holdings
LNTH
|
225 M | $ 80.04 | -0.68 % | $ 5.4 B | USA |
 |
Motus GI Holdings
MOTS
|
2.16 M | - | -34.28 % | $ 263 K | Israel |
 |
Senseonics Holdings
SENS
|
163 M | $ 6.54 | -2.1 % | $ 273 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
5.17 B | $ 191.24 | -0.15 % | $ 21.2 B | USA |
 |
Neogen Corporation
NEOG
|
19.6 M | $ 9.16 | -2.79 % | $ 1.99 B | USA |
 |
Soleno Therapeutics
SLNO
|
10.8 M | $ 52.56 | -0.13 % | $ 2.67 B | USA |
 |
ENDRA Life Sciences
NDRA
|
843 K | $ 5.0 | 1.21 % | $ 3.94 M | USA |
 |
Organovo Holdings
ONVO
|
588 K | - | -2.3 % | $ 19.4 M | USA |